Migraine Science Collaborative Editorial Board
Faisal Mohammad Amin, MD, PhD
Faisal Mohammad Amin, MD, PhD, is head of the Department of Neurology, Copenhagen University Hospital – Amager and Hvidovre Hospital, Hvidovre, Denmark, and an associate professor of neurology at the University of Copenhagen. He has authored more than 150 peer-reviewed publications, and his academic works focus on the use of advanced magnetic resonance imaging to investigate structural and functional cerebral biomarkers of migraine. In addition, he is leading a real-world anti-CGRP treatment registry in Denmark. He is considered among the leading experts on migraine and post-traumatic headache worldwide. Dr. Amin has previously served as president of the Danish Headache Society and vice-president of the Danish Neurological Society.
Hamid R. Djalilian, MD
Hamid R. Djalilian, MD, is a professor of otolaryngology, neurosurgery, and biomedical engineering, the director of otology and neurotology, and the Muzzy Family Endowed Chair in Hearing and Balance at the University of California Irvine. His research interests are in the role of migraine in ear and head and neck disorders, device development for the treatment of ear disorders, and population studies related to migraine, central sensitivity, and ear disorders. His basic science laboratory focuses on prevention of hearing loss, regeneration of hearing cells, and gene therapy. His clinical care focuses on complex surgical and medical issues of the ear and skull base.
Gregory Dussor, PhD
Gregory Dussor, PhD, is a professor and chair of the Department of Neuroscience at the University of Texas at Dallas. His work focuses on understanding how the sensory innervation of the meninges contributes to headache disorders. Using several preclinical models, his group has identified numerous targets within this afferent nociceptive system including several that may contribute to sex differences observed in migraine. Dr. Dussor has published over 110 peer-reviewed research articles and is on the editorial boards of Pain, Pain Reports, Molecular Pain, the Journal of Headache and Pain, and the Journal of Neuroscience.
Danielle Newport Fancher
Danielle Newport Fancher is a writer, migraine advocate, speaker and author of 10: A Memoir of Migraine Survival. She's received awards from the National Headache Foundation and the Association of Migraine Disorders for her writing and advocacy. She’s also a member of the Patient Leadership Council for the National Headache Foundation. To learn more, visit MigraineWriter.com or follow @MigraineWriter on Instagram, Facebook and Twitter.
Philip Holland, PhD
Philip Holland, PhD, is a translational neuroscientist who leads the preclinical headache group at King's College London. His research is focused on developing a greater understanding of the mechanisms underlying migraine and other primary headache disorders, with a current focus on how internal neural networks interact with environmental cues to alter attack susceptibility. A neuroscience graduate from Glasgow University, he then completed his PhD at UCL before postdoctoral work at UCL, UC San Francisco and the University of Edinburgh. He joined King's in 2013 and is now a reader in the Wolfson Sensory, Pain and Regeneration Centre (SPARC). When not leading the headache group, he is an active educator at King's, serves on the editorial board for several leading scientific journals/congresses, interacts with industry partners, is on the board of the European Headache Federation, and was recently acknowledged as a future leader in pain research by the Medical Research Foundation.
Shivang Joshi, MD, MPH, RPh, FAHS
Shivang Joshi, MD, MPH, RPh, FAHS, received his BPharm degree in pharmacy from St. John’s University College of Pharmacy and Allied Health Professions in New York City. He received his MD and MPH from St. George’s University School of Medicine in Grenada, West Indies, and completed his neurology residency at the Beth Israel Medical Center in New York City. Dr. Joshi then joined the Brigham and Women’s Hospital, John R. Graham Headache Center in Boston, Massachusetts, for a fellowship in headache medicine, where he was also an instructor of neuroscience at Harvard Medical School. He is board-certified in neurology and headache medicine. He is a recipient of the American Headache Society’s 2012 Frontiers in Headache Research Scholarship Award for cluster headache research. Some of his clinical interests include the trigeminal autonomic cephalalgias such as cluster headaches and migraine with aura in women. Dr. Joshi is also a member of several professional medical societies including the American Academy of Neurology and the American Headache Society. He is also a founding member of the Great Lakes Regional Headache Society and an executive board member of the Association of Migraine Disorders. He is actively involved with mentorship and education with his academic societies.
Tally M. Largent-Milnes, PhD
Tally M. Largent-Milnes, PhD, is an associate professor in pharmacology and member of the Comprehensive Center for Pain and Addiction and Bio5 Institute at the University of Arizona. She has worked in the pain field since 2003, trigeminal pain since 2010, and in migraine/headache specifically since 2015. Her lab interests meet in the midbrain pain pathways using preclinical models (cortical spreading depression, medication overuse headache) to understand the neurological underpinnings of migraine/headache behaviors during induction and maintenance. Molecular interests in the lab include elucidating the impact of endocannabinoid signaling and how fluctuations in neurosteroids (e.g. estrogens, progesterone, testosterone) levels play a role in headache pathophysiology. Her trainees include 4 MD/PhD students, 8 PhD students, and more than 50 undergraduate students since 2014. Outside of the lab, Dr. Largent-Milnes enjoys cycling, spending time with her family, reading historical fiction, and finding really good ice cream.
Dan Levy, PhD
Dan Levy, PhD, is an associate professor of anesthesia at Harvard Medical School. He received his PhD from the University of Calgary in 1999. He then completed his postdoctoral fellowship at Harvard Medical School/BIDMC. Dr. Levy has been the recipient of several NIH research project awards, the Harold Wolff-John Graham Award from the American Academy of Neurology, and the Cephalalgia award from the International Headache Society. Dr. Levy's research focuses on the sensory innervation of the intracranial meninges and its role in headaches, such as migraine. He has published over 60 research articles and book chapters on pain, headache, and migraine pain pathophysiology.
Antoinette Maassen van den Brink, PhD
Prof. dr. Antoinette Maassen van den Brink, PhD, is a professor of neurovascular pharmacology at the Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands. She studies the neurovascular aspects of migraine, with a special interest in the role of female sex hormones on its pathophysiology. Her research is translational in origin, including animal in vivo experimental models, human isolated tissue models, as well as human in vivo clinical models. She is immediate past president of the European Headache Federation and director of the School of Headache Essentials of the European Headache Federation. Further, she is a board member of the Dutch Headache Society and founding board member of the Dutch Society for Gender and Health. She has over 250 scientific publications in international, peer-reviewed journals and has received many prestigious research grants and awards from the American Headache Society, National Headache Foundation (USA), International Headache Society, Dutch Heart Foundation, Dutch Brain Foundation, the Netherlands Organisation for Health Research and Development, as well as the Dutch Research Council.
Nasim Maleki, PhD
Nasim Maleki, PhD, is an assistant professor of psychiatry at Harvard Medical School and a researcher at the Psychiatric Neuroimaging Division, Massachusetts General Hospital. She is a medical scientist and a medical physicist by training and has extensive experience in developing and applying advanced multimodal neuroimaging techniques to study brain structure, function, and chemistry to understand the mechanisms of brain disorders. Dr. Maleki’s research in migraine has been focused on understanding the pathophysiology of migraine disease through examining the sex-related contributions to the onset and evolution of the disease.
Hadas Nahman-Averbuch, PhD
Hadas Nahman-Averbuch, PhD, is an assistant professor at Washington University. She studies the hormonal, psychophysical, and neural factors contributing to the onset and prognosis of migraine in adolescents and adults. She also studies the comorbidities of migraine.
Amynah Pradhan, PhD
Amynah Pradhan, PhD, is director of the Center for Clinical Pharmacology at Washington University School of Medicine in St. Louis. Previously she was associate professor of psychiatry at the University of Illinois at Chicago. She investigates novel therapies for migraine and identified the delta opioid receptor as a promising target for this disorder. Ongoing studies in her lab are focused on the differential role of mu and delta opioid receptors in headache. Additionally, Dr. Pradhan’s work focuses on identifying the molecular mechanisms that contribute to migraine chronicity, as well as overlapping mechanisms between migraine and neuropsychiatric conditions.
Mandee Schaub, MS, PhD candidate
Mandee Kate Schaub, MS, is a researcher and PhD candidate in the Department of Neuroscience at the University of Texas at Dallas, and the trainee representative on the MSC editorial board. Her work focuses on the role of the trigeminal ganglion in the transmission of pain signals contributing to the pain phase of migraine and headache disorders. Using preclinical models and human tissue from organ donors, she aims to understand the pathophysiology of headache and identify new therapeutic targets. In addition to her research, Mandee is a person living with chronic migraine and persistent daily headache. She is passionate about reducing suffering of all people living with headaches and hopes to make a positive impact throughout her career with research, advocacy, and public education about migraine and headache disorders.
Elizabeth Seng, PhD
Elizabeth Seng, PhD, is a clinical health psychologist and a professor of health psychology at Yeshiva University and a professor of neurology at Albert Einstein College of Medicine. Her lab aims to harness behavior change to improve the lives of people living with migraine and other headache diseases.
Gretchen E. Tietjen, MD
Gretchen E. Tietjen, MD, a graduate of University of Michigan Medical School, is Distinguished University Professor Emerita of Neurology at University of Toledo. She founded the Department of Neurology in 1999 and led as an endowed Chair through 2019. Specializing in headache medicine and vascular neurology, she directed the Stroke Center for 15 years and the Headache Treatment and Research Center for 23 years. Her research focuses on the relationship of migraine and stroke, and includes investigation of the vascular biology in migraine, the association of childhood maltreatment and migraine, and the effects of early life stress on vascular and brain biology in a rodent model. Dr. Tietjen has published over 150 peer-reviewed papers, book chapters, reviews and editorials, and her research has garnered national awards, including the 2009 Stroke Innovation Award from the journal Stroke, the Association of Migraine Disorders' 2020 Innovation Award, as well as the American Headache Society’s 2008 Seymour Solomon Award, 2011 Harold G. Wolff Award, 2017 John Graham Award, 2019 Women’s Health Research Award, and 2022 Lifetime Achievement Award.
MSC also thanks its previous board members, including KC Brennan, Deena Kuruvilla, Daniela Pietrobon, and Carl Saab.